Skip to content

Perioperative application of SPI (surgical pleth index) in the monitoring of analgesia/ anti-nociception

Perioperative application of SPI (surgical pleth index) in the monitoring of analgesia/ anti-nociception

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000030145
Enrollment
Unknown
Registered
2020-02-24
Start date
2020-03-01
Completion date
Unknown
Last updated
2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesiology

Interventions

experimental group:SPI monitoring
control group:MAP monitoring

Sponsors

The Fourth Affiliated Hospital, Zhejiang University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Line selection in our hospital 100 cases undergoing elective general anesthesia surgery patients, ranging in age from 18 to 60 years of age, and gender not limited, ASA class is I ~ II.

Exclusion criteria

Exclusion criteria: 1. Allergic to narcotic drugs;Abnormal coagulation function; 2. Patients with serious cardiorespiratory disorders (pacemaker implantation, atrial fibrillation); 3. Endocrine diseases (diabetes, abnormal thyroid function); 4. Peripheral neuropathy and peripheral coldness; 5. Liver and kidney disease; 6. Patients with neurological complications; 7. Opioid abuse or drug users; 8. Using drugs such as beta blocker or clonidine to affect autonomic nerve regulation; 9. Pregnant women;Patients with poor hypertension control (SBP >= 160mmHg and/or DBP >= 100mmHg); 10. Obese patients (BMI >= 30); 11. Lean patients (BMI < 18.5); 12. Transfer to open surgery or reoperation after surgery.

Design outcomes

Primary

MeasureTime frame
Opioid dosages;Postoperative agitation, nausea and vomiting, NRS score, additional dose of analgesics, spontaneous breathing time, eye opening time, and extubation time were recorded in PACU.;Perioperative cortisol, il-6 and il-8 levels;The VAS score, the use of supplementary analgesics, the incidence of nausea and vomiting, pruritus, urinary retention, and the time of anal exhaust and feeding were observed within 3 days;

Secondary

MeasureTime frame
Propofol dosage, circulation status (blood pressure and heart rate);

Countries

China

Contacts

Public ContactJian Guo

The Fourth Affiliated Hospital, Zhejiang University, School of Medicine

guo86jian@zju.edu.cn+86 13858116560

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 15, 2026